Tags: Drug.

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide a triazole derivative was developed in 2004 by Novartis Pharma AG and is manufactured by Eisai.Rufinamide was approved by the US Food and Drug Administration on November 14 2008 as adjunctive treatment of seizures associated with Lennox-Gastaut syndromein children 4 years and older and adults.

Rufinamide.png
ATC prefix
N03
ATC suffix
AF03
CAS number
106308-44-5
FDA UNII code
WFW942PR79
IUPAC name
1-(26-difluorobenzyl)-1H-123-triazole-4-carboxamide
PubChem
129228

Loading...

This page contains content from the copyrighted Wikipedia article "Rufinamide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.